MiMedx Group, Inc. v. Tissue Transplant Technology, Ltd.
5:14-cv-00719
Overview
Parties
Defendant
Tissue Transplant Technology, Ltd. Operating Company
Represented By
3 Attorneys ListedGunn, Lee & Cave, PC
300 Convent St., Ste 1080
Gunn, Lee & Cave, P.C.
300 Convent Street, Suite 1080
Texas Human Biologics, Ltd. Operating Company
Represented By
3 Attorneys ListedGunn, Lee & Cave, PC
300 Convent St., Ste 1080
Gunn, Lee & Cave, P.C.
300 Convent Street, Suite 1080
Transplant Technology, Inc. Operating Company
Represented By
2 Attorneys ListedGunn, Lee & Cave, PC
300 Convent St., Ste 1080
Gunn, Lee & Cave, P.C.
300 Convent Street, Suite 1080
Plaintiff
Court & Judges
Court
District Court, W.D. Texas (txwd)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 17 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 8,597,687 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 8,623,421 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 8,709,494 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 9,433,647 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 9,463,207 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 2014033039 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 9,572,839 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 9,265,800 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 2015018266 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 9,272,005 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 9,265,801 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 9,956,253 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 11,504,449 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 10,406,259 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 2023020141 | US Continuation / Sibling | View Official Patent → |
Musculoskeletal Transplant Foundation et al. v. MiMedx Group, Inc.
Tissue Transplant Technology, Ltd. d/b/a Bone Bank Allografts et al. v. MiMedx Group, Inc.
TIGER MEDICAL HOLDINGS, LLC d/b/a TIGER BIOSCIENCES v. MIMEDX GROUP, INC.
Patents Involved
There are 3 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US8597687
Methods for determining the orientation of a tissue graft
|
Filed: 2012-08-07
Issued: 2013-12-03
|
Active (5.7 yrs remaining)
Expires: 2032-08-07
|
|
|
US8709494
Placental tissue grafts
|
Filed: 2013-07-30
Issued: 2014-04-29
|
Active (6.7 yrs remaining)
Expires: 2033-07-30
|
|
|
US8709484
Phospholipid-based powders for drug delivery
|
Filed: 2008-10-24
Issued: 2014-04-29
|
Expired (Term Ended)
Expires: 2022-03-07
|
Patent Enforceability & Injunction Risk Assessment
Active Threat — Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.
Standard Statutory Term — No obviousness-type double patenting truncation noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
104
Dispositive
22
Granted
49
Denied
1
Pending / Review
46
Motions by Category
Key Dispositive Motions & Rulings